Home > First stage of Russian Covid-19 vaccine clinical trials completed

Health
First stage of Russian Covid-19 vaccine clinical trials completed

Description

Moscow (Russia), 15 July (EFE/EPA) (Camera: Yury Kochetkov).- Russian researchers have completed the first phase of clinical trials for their COVID-19 vaccine. The progress was explained at a press conference at the Center of Science and Practice for Interventional Cardioangiology in Moscow. The vaccine was developed at the Gamaleya Research Institute of Epidemiology and Microbiology. FOOTAGE OF THE MOSCOW PRESS CONFERENCE WITH DR. VADIM TARASOV, DIRECTOR OF THE INSTITUTE FOR TRANSLATIONAL MEDICINE AND BIOTECHNOLOGY OF SECHENOV UNIVERSITY; ELENA SMOLYARCHUK, HEAD OF RESEARCH AND DIRECTOR OF THE CENTER FOR CLINICAL RESEARCH ON MEDICATIONS AT SECHENOV UNIVERSITY; AND SEMITKO SERGEI, DIRECTOR OF THE SCIENCE AND PRACTICE CENTER FOR INTERVENTIONAL CARDIOANGIOLOGY.

Added on the 15/07/2020 14:00:00 - Copyright : EFE Inglés

To customise your video :

Generic export code

More videos on the subject

Which Country Has Given The Most COVID-19 Vaccinations?

Which county has administered the most coronavirus vaccine injections? More than 40 countries around the world have begun the vaccination process. According to Business Insider, rich and middle-income countries have secured almost all the available vaccine supply. According to data, the U.S. had administered roughly 1.94 million COVID-19 vaccine doses. Following behind the U.S. is China, which has administered at least 1 million COVID-19 vaccine doses. Across the world, there have been more than 4.3 million COVID-19 vaccine doses given.

16/01/2021 - Wochit
Moderna CEO Says Coronavirus Will Be Here Forever

15/01/2021 - Wochit
CDC Expands COVID-19 Vaccine Priority

The US Department of Health and Human Services expanded COVID-19 vaccine availability. The agency said they will now include people age 65 and older in the initial phase of distribution. According to UPI, the changes also give priority to those with underlying health conditions. People of any age with underlying health conditions are at higher risk for serious illness from COVID-19 infection. In addition to expanding the priority population, HHS will also be releasing the nation's "entire supply" of vaccines. As of Tuesday, just 9 million of the 25 million vaccine doses distributed had been administered.

14/01/2021 - Wochit
Ohio Researchers Identify New Covid Strains

13/01/2021 - Wochit
Seniors Struggling With COVID Vaccine Websites

13/01/2021 - Wochit